Clinical Trial Update: Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the safety, tolerability, and efficacy of macitentan in adults with inoperable chronic thromboembolic pulmonary hypertension ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• OPSUMIT (macitentan)

Snippet

Sponsor: Actelion | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-04-11